TMO — Thermo Fisher Scientific Inc. stock price and chart

TMO

Thermo Fisher Scientific Inc.Stock · HealthcareS&P 500 0.3% · Russell 1000 0.3% · US Stock Market 0.3% · Russell 3000 0.3% · MSCI World 0.2% · S&P 500 Equal Weight 0.2% · MSCI ACWI 0.2%

$609.82+1.10%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKABBV

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

150.0200.0250.0300.0350.0400.0450.0500.0550.0600.0650.0010.0M20.0M$609.82

2026-09-11

Price$609.82

MA20$523.22

MA50$524.69

Vol11.0M

What would $1,000 invested in TMO be worth today? →

TMO returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $609.82
Change YTD: +5.45%
Next earnings: Oct 28, 2026
Market cap: 225.5B2016-09 62.7B2026-09 225.5B+259.6% over the window
Enterprise value: 268.8B
Shares outstanding: 369.7M2016-07 394.3M2026-06 369.7M-6.2% over the window
52W low: $435.27
52W high: $647.00
From 52W high: -5.75%
From 52W low: +40.10%
52W range: 82%
Beta: 0.85

Volume

Rel volume: 1.05×
30D volume: 1.7M
30D $ vol: 1B

Fundamentals

Sales (ttm): 46.3B2016-07 17.6B2026-06 46.3B+163.2% over the window
Sales/share: $125.322016-07 $44.652026-06 $125.32+180.6% over the window
EPS (ttm): $18.582016-07 $4.992026-06 $18.58+272.3% over the window
FCF (ttm): 7.3B2016-07 2.9B2026-06 7.3B+153.7% over the window
FCF/share: $19.792016-07 $7.322026-06 $19.79+170.5% over the window
Book value/share: $142.472016-07 $53.932026-06 $142.47+164.2% over the window
Net margin: 15.04%2016-07 11.3%2026-06 15.0%+32.5% over the window
ROE: 13.23%2016-07 9.4%2026-06 13.2%+40.8% over the window
ROA: 6.16%2016-07 4.7%2026-06 6.2%+30.2% over the window
Debt / equity: 0.80×2016-07 0.552026-06 0.80+46.7% over the window
Current ratio: 1.552016-07 1.152026-06 1.55+35.4% over the window

Growth (CAGR, ttm) · 10Y

Sales: +7.26%2025-06-28 → 2026-06-2743.2B → 46.3B (+7.2% total)+2.12%2023-07-01 → 2026-06-2743.5B → 46.3B (+6.5% total)+3.92%2021-07-03 → 2026-06-2738.3B → 46.3B (+21.1% total)+10.18%2016-07-02 → 2026-06-2717.6B → 46.3B (+163.2% total)
Net income: +5.84%2025-06-28 → 2026-06-276.6B → 7B (+5.8% total)+6.78%2023-07-01 → 2026-06-275.7B → 7B (+21.7% total)-4.14%2021-07-03 → 2026-06-278.6B → 7B (-19.0% total)+13.33%2016-07-02 → 2026-06-272B → 7B (+248.8% total)
FCF: +18.68%2025-06-28 → 2026-06-276.2B → 7.3B (+18.6% total)+7.75%2023-07-01 → 2026-06-275.9B → 7.3B (+25.0% total)-2.09%2021-07-03 → 2026-06-278.1B → 7.3B (-10.0% total)+9.77%2016-07-02 → 2026-06-272.9B → 7.3B (+153.7% total)
Shares: -2.09%2025-06-28 → 2026-06-27377.6M → 369.7M (-2.1% total)-1.42%2023-07-01 → 2026-06-27385.9M → 369.7M (-4.2% total)-1.24%2021-07-03 → 2026-06-27393.4M → 369.7M (-6.0% total)-0.64%2016-07-02 → 2026-06-27394.3M → 369.7M (-6.2% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +7.54%2025-06-28 → 2026-06-27$17.28 → $18.58 (+7.5% total)+8.24%2023-07-01 → 2026-06-27$14.66 → $18.58 (+26.7% total)-3.00%2021-07-03 → 2026-06-27$21.62 → $18.58 (-14.1% total)+14.07%2016-07-02 → 2026-06-27$4.99 → $18.58 (+272.3% total)
Sales/share: +9.54%2025-06-28 → 2026-06-27$114.43 → $125.32 (+9.5% total)+3.59%2023-07-01 → 2026-06-27$112.77 → $125.32 (+11.1% total)+5.23%2021-07-03 → 2026-06-27$97.22 → $125.32 (+28.9% total)+10.89%2016-07-02 → 2026-06-27$44.65 → $125.32 (+180.6% total)
FCF/share: +21.21%2025-06-28 → 2026-06-27$16.34 → $19.79 (+21.1% total)+9.31%2023-07-01 → 2026-06-27$15.17 → $19.79 (+30.5% total)-0.87%2021-07-03 → 2026-06-27$20.67 → $19.79 (-4.2% total)+10.48%2016-07-02 → 2026-06-27$7.32 → $19.79 (+170.5% total)
Book value/share: +6.53%2025-06-28 → 2026-06-27$133.77 → $142.47 (+6.5% total)+7.94%2023-07-01 → 2026-06-27$113.36 → $142.47 (+25.7% total)+8.78%2021-07-03 → 2026-06-27$93.68 → $142.47 (+52.1% total)+10.22%2016-07-02 → 2026-06-27$53.93 → $142.47 (+164.2% total)
Dividend/share: +9.79%2025-06-28 → 2026-06-27$1.64 → $1.80 (+9.8% total)+11.50%2023-07-01 → 2026-06-27$1.30 → $1.80 (+38.5% total)+13.45%2021-07-03 → 2026-06-27$0.96 → $1.80 (+87.5% total)+11.63%2016-07-02 → 2026-06-27$0.60 → $1.80 (+200.0% total)
Price: +24.11%2025-09-11 → 2026-09-11$491.41 → $609.82 (+24.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+5.80%2023-09-11 → 2026-09-11$514.94 → $609.82 (+18.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.29%2021-09-10 → 2026-09-11$571.96 → $609.82 (+6.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.55%2016-09-09 → 2026-09-11$143.68 → $609.82 (+324.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +24.57%2025-09-11 → 2026-09-11$489.63 → $609.82 (+24.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+6.14%2023-09-11 → 2026-09-11$510.02 → $609.82 (+19.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.57%2021-09-10 → 2026-09-11$564.02 → $609.82 (+8.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.88%2016-09-09 → 2026-09-11$139.63 → $609.82 (+336.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 32.8×2016-09 31.392026-09 32.37+3.1% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 27.7×2016-09 26.042026-09 27.68+6.3% over the window
Fwd P/E: 22.3×
P/S (ttm)Market cap ÷ TTM revenue.: 4.9×2016-09 3.562026-09 4.87+36.6% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 4.3×2016-09 2.952026-09 4.28+45.1% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 30.8×2016-09 21.742026-09 30.81+41.8% over the window
EV/EBITDA (fy): 26.4×
EV/Sales (ttm): 5.8×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 3.25%2016-07 4.6%2026-06 3.9%-14.5% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.30%
Dividend/share (fwd): $1.80
Buyback yield (realized, 1y)1 − shares_at(2026-06-27) ÷ shares_at(2025-06-28) = 1 − 369.7M ÷ 377.6M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 2.09%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (2.09%) + dividends paid over that year ($662M) ÷ market_cap_at(2025-06-28) ($154.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 2.52%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($5B) ÷ today's market cap ($225.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 2.22%2016-07 1.6%2026-06 2.7%+68.5% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $5B + TTM dividends $662M) ÷ today's market cap ($225.5B). Same caveat as the cash buyback yield.: 2.51%2016-07 2.0%2026-06 3.0%+53.9% over the window

Vs own 10Y history

P/E: 51st
P/OI: 62nd
P/S: 59th
P/B: 52nd
P/FCF: 68th

Bar = where today’s multiple sits in TMO’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+1.10%

-1.39%

+1.13%

+28.33%

YTD

+5.45%

+28.43%

+9.36%

Financial statements

Open full TMO financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
ABBV	AbbVie Inc.	+3.36%	+0.83%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%
ABT	Abbott Laboratories	-8.08%	-1.36%

Thermo Fisher Scientific Inc. (TMO) trades at $609.82 with a live price and an interactive chart covering 42+ years of daily price history, plus key valuation metrics. ChartRow also publishes TMO’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full TMO financial statements →

TMO — Thermo Fisher Scientific Inc. price, chart and key statistics